Market Share of Artificial Intelligence in Drug Discovery Industry
The artificial intelligence in the drug discovery market is moderately consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international as well as local companies that hold market shares and are well known, including Microsoft, IBM, Exscientia, GNS Healthcare, Alphabet, Benevolent AI, Cloud, NVIDIA Corporation, DEEP GENOMICS, Neumora, Recursion, Notable, Insilico Medicine, and PathAI.
AI in Drug Discovery Market Leaders
-
Microsoft
-
IBM
-
Exscientia
-
GNS Healthcare
-
Alphabet
*Disclaimer: Major Players sorted in no particular order